Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$27.42 - $43.63 $176,968 - $281,588
-6,454 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$33.11 - $55.01 $213,691 - $355,034
6,454 New
6,454 $281,000
Q3 2020

Nov 05, 2020

SELL
$81.91 - $134.94 $229,266 - $377,697
-2,799 Closed
0 $0
Q2 2020

Jul 28, 2020

BUY
$54.33 - $89.52 $152,069 - $250,566
2,799 New
2,799 $221,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $493M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.